Sometimes the market gets fairly excited about a perceived significant event causing a lot of would-be investors to jump into an investment without properly weighing all the potential risks and outcomes. Cobas Asset Management invested in Teekay Corporation (TK) to the tune of about 4 million sha
San Francisco, California-based Twitter Inc (NYSE:TWTR)has given investors quite a few things to cheer about this year. Yet, TWTR stock is down by over 22% for the year so far, even after a ~20% rally in the last six months. Beyond the reasonable success Twitter has seen in live streaming, the micro blogging site has recorded many other positives as well. From generating positive free cash flows....More>>>
Apple Inc.’s services segment could be worth over $240B, making it a big reason to buy AAPL stock.
Shares of Cupertino, California-basedApple (NSDQ:AAPL) were recently namedby RBC capital markets’ analysts among the top tech stock picks for 2017. This is in stark contrast to 2016, a year in which AAPL stock has barely managed to beat the S&P 500 (INDX:SPAL). Apple stock....More>>>
Dear Mr. Trump, First, I would like to apologize for all the insightful and well-informed things I have written about you. But please keep in mind the context in which those remarks were made. Honestly, I think you're tremendous. Tremendous. I love you. You are an imbecile, it's true. But at least you are not a conniving, power-grasping, finger-pointing harpy. You at....More>>>
bluebird bio, (NASDAQ:BLUE) is one of the oncology immunotherapy stocks I mentioned recently as worth a good look, (article titled ‘Immunotherapy Over Reaction’, a basic primer to the immunotherapy subsector and its ETF). BLUE is also a recent Cramer pick. Immunotherapy stocks have been hit hard over the summer but BLUE is a relatively highly valued genetic specialist, with some interesting....More>>>
Shares of Halliburton (HAL) and Baker Hughes (BHI) are soaring after they announced that they’d challenge the U.S. Department of Justice’s decision to block their merger. RBC’s Kurt Hallead has the details:
Shares of both companies rose ~5% following the joint press release indicating they would challenge the DoJ’s decision to oppose....More>>>
President-elect Donald Trump warns he’ll impose big tariffs on goods from Mexico to protect blue collar jobs in America.
But Trump may want to take note of how similar tariffs have played out in Argentina. In 2009, that country put a 35% tariff on computers, tablets and other electronics in order to shield its manufacturing workers. It’s the same size as Trump’s proposed....More>>>
Strategas Research Partners’ Jason DeSena Trennert and Ryan Grabinski wonder what impact Valeant Pharmaceuticals International’s (VRX) current woes will have on other so-called platform companies,Endo International (ENDP), Allergan (AGN), and Danaher (DHR) among them:
Valeant’s recent difficulties might warrant a second look at platform companies…We dont mean to pile....More>>>
I (Porter) know a headline like that will leave me with only about five people still reading. So let me try again... The next 18 months will likely see: a terrible bear market... a substantial economic recession... and a great opportunity for you to buy high-quality businesses at reasonable p
"Big Three" U.S. automaker General Motors (GM) is finally admitting the obvious... The boom in auto sales is peaking. As news service Reuters reported following the company's conference call on Monday... "The market is definitely slowing... it's s
The technology sector has been lagging the broad-based market over the past month. It seems like it may be the beginning of a corrective pullback. I dont expect a significant correction but any weakness will be a good opportunity to buy The Priceline Group (PCLN). The online travel industry is se